Transcontinental (TSE:TCL.A – Get Free Report) had its price target hoisted by Scotiabank from C$19.50 to C$22.00 in a research report issued on Friday,BayStreet.CA reports. Scotiabank’s price objective would indicate a potential upside of 21.68% from the company’s previous close.
A number of other research analysts also recently weighed in on TCL.A. BMO Capital Markets increased their price objective on shares of Transcontinental from C$16.50 to C$18.00 and gave the company a “market perform” rating in a research report on Friday, September 13th. CIBC increased their price target on Transcontinental from C$18.00 to C$19.00 and gave the company an “outperform” rating in a report on Monday, September 16th. Finally, Royal Bank of Canada raised their price target on Transcontinental from C$22.00 to C$23.00 in a research note on Tuesday, December 10th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, Transcontinental presently has a consensus rating of “Moderate Buy” and an average target price of C$21.75.
Check Out Our Latest Report on TCL.A
Transcontinental Price Performance
Transcontinental Company Profile
Transcontinental Inc engages in flexible packaging business in Canada, the United States, Latin America, the United Kingdom, Australia, and New Zealand. It operates through three segments: Packaging, Printing, and Media. The Packaging segment engages in extrusion, lamination, printing, and converting activities, as well as offers flexible plastic and paper products, including rollstock, bags and pouches, coextruded films, shrink films and bags, and advanced coatings.
Featured Articles
- Five stocks we like better than Transcontinental
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- 3 Tickers Leading a Meme Stock Revival
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Using the MarketBeat Dividend Tax Calculator
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Transcontinental Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcontinental and related companies with MarketBeat.com's FREE daily email newsletter.